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A highly stable modular platform, based on the sequential covalent attachment of different functionalities
to the surface of core–shell mesoporous silica nanoparticles (MSNs) for targeted drug delivery is pres-
ented. A reversible pH-responsive cap system based on covalently attached poly(2-vinylpyridine) (PVP)
was developed as drug release mechanism. Our platform offers (i) tuneable interactions and release kine-
tics with the cargo drug in the mesopores based on chemically orthogonal core–shell design, (ii) an
extremely robust and reversible closure and release mechanism based on endosomal acidification of the
covalently attached PVP polymer block, (iii) high colloidal stability due to a covalently coupled PEG shell,
and (iv) the ability to covalently attach a wide variety of dyes, targeting ligands and other functionalities at
the outer periphery of the PEG shell. The functionality of the system was demonstrated in several cell
studies, showing pH-triggered release in the endosome, light-triggered endosomal escape with an on-
board photosensitizer, and efficient folic acid–based cell targeting.
1. Introduction
Polymers can be attractive for biological applications due to
their biocompatibility, tuneable properties and production
from sustainable sources.1,2 Therefore, polymers are widely
used as responsive coatings of surfaces for selective ion-per-
meability,3 surface patterning4,5 and drug delivery with poly-
plexes,1,6,7 hybrid dendrimers,8,9 and other drug-polymer
conjugates.10,11 Regarding drug-polymer conjugates, which
offer relatively small particle sizes and good biocompatibility,
possible issues may arise from low loading capacities and
potentially poor stability, depending on the strength of the
drug-polymer interactions.12,13 The drug-polymer interactions
need to be optimized for different kinds of drugs to ensure
stable drug-polymer conjugates. Aimed at creating a more
general delivery platform, much effort has been extended
towards the development of inorganic nanoparticles such as
mesoporous silica nanoparticles (MSNs) for the delivery of bio-
active compounds to cells and tumors.14–18 MSNs have a high
loading capacity and can be functionalized internally and on
the external surface.19 To prevent premature release from these
mesoporous systems, different strategies including covalent
attachment of the cargo inside the mesopore or complete
capping of the whole particle have been developed.20–26
The release mechanisms include changes in reduction
potential,27,28 pH,20–22,29–31 temperature,32–34 and irradiation
with light.16,35–37
Combining the high loading capacity and stability of meso-
porous nanoparticles with the biocompatibility and tuneable
properties of polymers offers the possibility to create stimuli-
responsive and reversible delivery systems. Drug delivery
vehicles based on nanoparticles in a size range of around
100 nm are likely to be taken up by cells via endocytosis.38
During this process, the endosome is being acidified by the
action of proton pumps.39,40 Therefore, pH-responsive polymer
coatings around mesoporous silica nanoparticles offer the
possibility to use the changes in pH during endocytosis as
trigger for controlled release. For instance, attachment of
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poly(N-isopropylacrylamide) (PNiPAM)34,41 poly(acrylic acid),42
chitosan,43,44 polyethylenimine (PEI),45 gelatin46 or poly(2-(di-
ethylamino)ethyl methacrylate)47 amongst others48 showed the
ability of pH-responsive functional polymer coatings around
mesoporous silica nanoparticles for release applications. Liu
et al. reported on different release kinetics from mesoporous
silica by the use of poly(4-vinylpyridine) as pH-responsive shell
created by multipoint anchoring.22 Poly(2-vinylpyridine) (PVP)
has also been used for the pH-sensitive micropatterning of sur-
faces, due to the pronounced transition between hydrophilicity
and hydrophobicity upon protonation and deprotonation.4
Here, we describe a multifunctional drug delivery vehicle
that combines the high loading capacity of a mesoporous
silica core with the environmental sensitivity of a pH-respon-
sive polymer (poly(2-vinylpyridine). The highly promising
feature of our system is the covalent attachment of the
polymer which makes the system more stable and the opening
mechanism presumably reversible. Additionally, the bi-func-
tional polymer can be functionalized on its ends with various
groups, e.g. polymers like poly(ethylene glycol) (PEG) to
increase the enhanced permeability and retention (EPR) effect,
targeting ligands or additional endosomal opening groups like
photosensitizers. At pH values around 5.5 or higher, the
polymer is deprotonated producing a hydrophobic state, which
causes a collapse of the polymer onto the silica surface, thus
preventing release of the cargo. After endocytic uptake of the
particles by a cell, the endosomes are acidified and the change
in pH can automatically lead to a switch of the particle into its
open state. Thus cargo loaded into the mesopores is released
into the endosomal compartment. For membrane-imperme-
able cargo, an additional release mechanism to open the endo-
some is necessary; therefore we also introduced a
photosensitizer (AlPcS2a) in our system. To maintain colloidal
dispersibility for these particles, even in the hydrophobic
closed state, PEG blocks were attached to the ends of the PVP
cap system. The use of α-, ω-bis-functionalized polymers offers
the possibility for anchoring any functionality of interest
(photosensitizer, targeting ligands) to the MSNs. With this
multifunctional system we perform cellular uptake and target-
ing experiments and show the triggered release induced by
pH-changes and photoactivation in living cells.
2. Experimental section
2.1. Chemicals
All reagents were purchased from commercial suppliers: tetra-
ethyl orthosilicate (TEOS, Sigma-Aldrich, >98%), cetyltri-
methylammonium chloride (CTAC, Fluka, 25 wt% in H2O),
triethanolamine (TEA, Sigma-Aldrich, 98%), (3-aminopropyl)-
triethoxysilane (APTES, Fluka, 95%), (3-mercaptopropyl)-
triethoxysilane (MPTES, Gelest, 95%), N-(3-dimethyl-
aminopropyl)-N-ethylcarbodiimide hydrochloride (EDC,
Sigma-Aldrich, 97%), ammonium nitrate (Sigma-Aldrich,
99%), conc. hydrochloric acid (Sigma-Aldrich, >95%, 37 wt%),
α-amino-ω-carboxy terminated poly(2-vinylpyridine) (NH2-
PVP-COOH, Polymer source, Mn = 10 000, PDI = 1.08), α,ω-poly-
ethyleneglycolbisamine (NH2-PEG-NH2, Sigma-Aldrich, Mn =
2000), Boc anhydride (Aldrich, 95%), folic acid (FA, Sigma,
>97%), aluminium (lll) phthalocyanine chloride tetrasulfonic
acid (AlPcS2a, Frontier Scientific), N-hydroxysulfosuccinimide
sodium salt (sulfo-NHS, Sigma-Aldrich, 98%), 4,6-diamidino-2-
phenylindole dihydrochloride (DAPI, Sigma-Aldrich, ≥98%),
calcein (Sigma-Aldrich), fluorescein sodium salt (Sigma-
Aldrich, BioReagent), dimethyl sulfoxide (DMSO, Sigma-
Aldrich, >99.5%), ethanol (EtOH, Sigma-Aldrich, >99.5%),
dichloromethane (anhydrous, Sigma-Aldrich, >99.5%), tetra-
hydrofuran (anhydrous, Sigma-Aldrich, ≥99.9%), trifluoro-
acetic acid (TFA, Acros Organics, 99%), oxalic acid dihydrate
(Sigma-Aldrich, >99%), magnesium sulfate (MgSO4, anhy-
drous, Sigma-Aldrich, ≥99.5%), triethylamine (Sigma-Aldrich,
≥99%), saline-sodium citrate buffer concentrate (SSC-buffer
(20×), Sigma-Aldrich), citric acid buffer solution (citric acid/
HCl/NaCl buffer, pH2, Sigma-Aldrich), doxorubicin hydrochlo-
ride (Dox, Sigma-Aldrich, D1515, 98–102%).
All chemicals were used as received without further purifi-
cation. Doubly distilled water from a Millipore system (Milli-Q
Academic A10) was used for all synthesis and purification
steps.
Wheat germ agglutinin (WGA) Alexa Fluor 488 conjugate
(life technologies), Atto 633 maleimide (ATTO-TEC).
2.2. Materials synthesis
Preparation of shell-functionalized colloidal mesoporous
silica nanoparticles (MSN-NH2). MSN nanoparticles were pre-
pared by a delayed co-condensation approach as described
earlier by Cauda et al.19 In detail, a two phase mixture of TEA
(14.3 g) and TEOS (1.9 g, 9.12 mmol) was heated at 90 °C for
20 minutes without stirring. After removal of the oil bath, a
preheated (60 °C) solution of CTAC (2.14 mL, 1.62 mmol,
25 wt% in H2O) and water (21.7 g) was added and stirred after-
wards at 500 rpm for 30 min at room temperature. Sub-
sequently, a mixture of 3-aminopropyltriethoxysilane (22.5 µL,
96 µmol) and TEOS (20.5 µL, 92 µmol) was added. The result-
ing solution was stirred overnight at room temperature at
500 rpm. Extraction of the organic template was achieved by
heating the ethanol-suspended sample (10 mg mL−1) under
reflux at 90 °C for 1 h in a mixture of 2 g ammonium nitrate
and 100 mL ethanol. Afterwards, the sample was centrifuged
for 20 minutes at 19 000 rpm (43 146 rcf), redispersed in
ethanol and heated under reflux at 90 °C in a solution of 8 mL
concentrated HCl and 32 mL ethanol for 45 minutes. After cen-
trifugation, the particles were re-dispersed in ethanol, result-
ing in a colloidal suspension.
Protection of NH2-PVP-COOH (Boc-PVP-COOH). To a solu-
tion of 500 mg (5 µmol) NH2-PVP-COOH in 10 mL dry
dichloromethane, triethylamine (15 µL, 0.11 mmol) and Boc
anhydride (15 mg, 6.9 µmol) were added. The solution was
stirred overnight and extracted several times with brine. The
organic phase was dried over MgSO4 and the solvent removed
in vacuo to yield the Boc protected polymer. The polymer was
used without further purification.
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General procedure for the attachment of poly(2-vinyl pyri-
dine) to MSN-NH2 (MSN-PVP-Boc). To a colloidal solution of
MSN-NH2 (50 mg), tetrahydrofuran (THF, 10 mL) and the Boc
protected polymer (60 mg, 5.6 µmol) dissolved in 1.5 mL THF
were added. The amidation was activated by the addition of
EDC (10 µL, 57.2 µmol) and Sulfo-NHS (1.3 mg, 6 µmol). The
mixture was stirred at room temperature for 12 h. Afterwards
the particles were separated by centrifugation (19 000 rpm,
43 146 rcf, 20 min) and washed 3 times by repeated centrifu-
gation and redispersion in 30 mL THF.
Deprotection of MSN-PVP-Boc (MSN-PVP-NH2). Deprotection
of the polymer was achieved through stirring 10 mg polymer
functionalized particles in a mixture of 2 mL trifluoroacetic
acid and 8 mL water for 24 h. After deprotection, the particles
were extensively washed by centrifugation (19 000 rpm, 43 146
rcf, 20 min) and redispersion in a mixture of 0.01 M HCl and
EtOH.
Conversion of MSN-PVP-NH2 to MSN-PVP-COOH. 10 mg
MSN-PVP-NH2 in 2 mL EtOH were reacted with a large excess
of oxalic acid (5 mg, 55 µmol) and EDC (9 µL, 51 µmol) for 1 h.
Afterwards the particles were extensively washed by centrifu-
gation (19 000 rpm, 43 146 rcf, 20 min) and redispersion in a
mixture of 0.01 M HCl and EtOH.
PEGylation of MSN-PVP-COOH (MSN-PVP-PEG-NH2). To a
colloidal solution of MSN-PVP-COOH (1 mg) in 500 µL EtOH,
NH2-PEG-NH2 (2 mg, 100 nmol – dissolved in 500 µL bidis-
tilled water) was added. Afterwards EDC (0.5 µL, 2.8 µmol) was
added and the reaction was allowed to stir at ambient tempera-
ture for 1 h. The sample was purified by subsequent centrifu-
gation (4 min, 14 000 rpm, 16 873 rcf) with a mixture of EtOH–
water 1 : 1. The washing step was repeated three times with
1 mL each.
Attachment of folic acid to MSN-PVP-PEG-NH2
(MSN-PVP-PEG-NH2-FA). The amino functionalities of
MSN-PVP-PEG-NH2 (1 mg, in 1 mL EtOH–water 1 : 1) were par-
tially reacted with folic acid (0.44 µg, 1 nmol). Subsequently
EDC (0.5 µL, 2.8 µmol) and a catalytic amount of Sulfo-NHS
(∼1 mg) were added. After 1 h, the sample was washed 3 time
by subsequent centrifugation (4 min, 14 000 rpm, 16 873 rcf)
and re-dispersion with a mixture of EtOH–water 1 : 1.
Attachment of AlPcS2a to residual amino groups of
MSN-PVP-PEG-NH2-FA (MSN-PVP-PEG-FA-AlPcS2a). To the
sample MSN-PVP-PEG-NH2-FA (1 mg) in 1 mL DMSO–water
1 : 1 20 µL of AlPcS2a (1 mg mL
−1 in DMSO) was added. The
resulting mixture was stirred at room temperature in the dark
for 24 hours. The sample was washed extensively with DMSO–
water 1 : 1 by repeated centrifugation (4 min, 14 000 rpm,
16 873 rcf) and re-dispersion until no photosensitizer could be
detected in the supernatant.
2.3. Release experiments
Drug/dye loading. 1 mg MSN-PVP-PEG-NH2 were dispersed
in 500 µL of a 1 mM drug/dye solution in water. For doxorubi-
cin loading, 1 mg MSN-PVP-PEG-NH2 was dispersed in 990 µL
ethanol and 10 µL doxorubicin (100 mg mL−1 in DMSO). To
open the pores and enable the uptake, 50 µL of citrate buffer
(pH 2) were added. The particles were stirred overnight, centri-
fuged, and redispersed in 1 mL SSC buffer (pH 7) to trigger
closure of the polymer shell. The particles were washed exten-
sively with SSC buffer until no fluorescence was detected in
the supernatant.
In vitro fluorescein release. 1 mg fluorescein loaded
MSN-PVP-NH2 or MSN-PVP-PEG-NH2 were re-dispersed in
200 µL SSC buffer and transferred to the cap of the fluorescence
cuvette. This cap was sealed with a dialysis membrane (mole-
cular weight cutoff of 16 000 g mol−1) and placed on top of the
fluorescence cuvette, which was also filled with SSC buffer. The
“release” of fluorescein out of the closed particles was moni-
tored for 2 h (λex = 490 nm, λem = 512 nm). Subsequently, the
cap was removed and the particles were centrifuged and redis-
persed in 200 µL citrate–phosphate buffer (pH 5), before being
put into the cap of the release setup. The fluorescence cuvette
was also filled with citrate–phosphate buffer (pH 5). After reas-
sembling the release setup, the release of fluorescein was con-
tinuously measured for 10 h. For comparison of the obtained
curves, calibration curves of fluorescein in SSC buffer (pH 7)
and in citrate–phosphate buffer (pH 5) were recorded.
2.4. Characterization
All samples were investigated with a FEI Titan 80–300 operat-
ing at 300 kV with a high-angle annular dark field detector. A
droplet of the diluted MSN solution in absolute ethanol was
dried on a carbon-coated copper grid. Nitrogen sorption
measurements were performed on a Quantachrome Instru-
ments NOVA 4000e. All samples (15 mg each) were heated to
60 °C for 12 h in vacuum (10 mTorr) to outgas the samples
before nitrogen sorption was measured at 77 K. Pore size and
pore volume were calculated by a NLDFT equilibrium model of
N2 on silica, based on the desorption branch of the isotherms.
In order to remove the contribution of the interparticle textural
porosity, pore volumes were calculated only up to a pore size of
8 nm. A BET model was applied in the range of 0.05–0.20 p/p0
to evaluate the specific surface area of the samples. Centrifu-
gation was performed using a Sorvall Evolution RC equipped
with a SS-34 rotor or an Eppendorf centrifuge 5418 for small
volumes. Raman spectra were recorded on a Jobin Yvon
Horiba HR800 UV Raman microscope using a He–Ne laser
emitting at λ = 633 nm. Dynamic light scattering (DLS)
measurements were performed on a Malvern Zetasizer-Nano
instrument equipped with a 4 mW He–Ne laser (633 nm) and
an avalanche photodiode. The hydrodynamic radius of the par-
ticles was determined by dynamic light scattering in ethanolic
suspension. For this purpose, 100 µL of an ethanolic suspen-
sion of MSN (ca. 10 mg mL−1) was diluted with 3 mL of
ethanol prior to the measurement. Zeta potential measure-
ments of the samples were performed on a Malvern Zetasizer-
Nano instrument equipped with a 4 mW He–Ne laser (633 nm)
and an avalanche photodiode. Zeta potential measurements
were performed using the add-on Zetasizer titration system
(MPT-2) based on diluted NaOH and HCl as titrants. For this
purpose, 1 mg of the particles was diluted in 10 mL bi-distilled
water. IR measurements were performed on a Bruker Equinox
Nanoscale Paper































































































55 FTIR/FTNIR Spectrometer in absorbance mode (spectra
were background substracted). UV-VIS spectra were recorded
with a NanoDrop ND 1000 spectrometer. Usually, 2 µL of
sample were used and all presented spectra are background
corrected for water absorption.
2.5. Cell culture and in vitro experiments
Cell culture. KB cells were grown in folic acid deficient
Roswell Park Memorial Institute 1640 medium (RPMI 1640,
life technologies) supplemented with 10% fetal bovine serum
(FBS). HeLa cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM)–F12 (1 : 1) (life technologies) with Glutamax
I medium supplemented with 10% FBS. Tubulin-GFP expres-
sing HuH7 cells were grown in Dulbecco’s modified Eagle’s
medium–F12 (1 : 1) supplemented with 10% FBS. All cells were
cultured at 37 °C in a 5% CO2 humidified atmosphere. KB
cells were seeded on ibidiTreat μ-Slides (IBIDI). HeLa and
tubulin green fluorescent protein (GFP) expressing HuH7 cells
were seeded on collagen A – coated LabTek chambered cover
glass (Nunc). For live cell imaging the cells were seeded 48 or
24 h before measuring, at a cell density of 1 × 104 or 2 × 104
cells cm−2, respectively.
Spinning disc confocal microscopy. Live-cell imaging was
performed on a confocal setup based on the Zeiss Cell Obser-
ver SD, utilizing a Yokogawa spinning disc unit CSU-X1. The
system was equipped with a 1.40 NA 100× or 63× Plan apochro-
mat oil immersion objective from Zeiss. The exposure time
was 0.1 s for all experiments und the frame rate varied
between 3 frames s−1 and 1 frame/30 s, depending on the
experiment. Calcein, WGA 488 and GFP were imaged with
approximately 0.39, 0.29 and 1.1 W mm−2 of 488 nm excitation
light. Atto 633 was imaged with approximately 0.06 W mm−2
of 639 nm excitation light and DAPI with 0.16 W mm−2,
respectively. The photosensitizer AlPcS2a was excited with
approximately 0.12 W mm−2 at 639 nm for imaging and with
1.2 W mm−2 for photoactivation. A quad-edge dichroic beam-
splitter (FF410/504/582/669-Di01-25x36, Semrock) was used in
the excitation path. For the two-color detection of calcein and
AlPcS2a, WGA 488 and Atto 633 or GFP and Atto 633, a dichroic
mirror (660 nm, Semrock) and band-pass filters 525/50 and
690/60 (both semrock) were used in the detection path. Separ-
ate images for each fluorescence channel were acquired using
two separate electron multiplier charge coupled device
(EMCCD) cameras (Photometrics Evolve™).
Uptake studies. The functionality of the folic acid targeting
ligand was evaluated in a receptor competition experiment.
For this purpose, one part of the KB cells was preincubated
with 3 mM folic acid (Sigma-Aldrich), to block the receptors,
for 2 h at 37 °C under a 5% CO2 humidified atmosphere. Then
the KB cells were incubated with particles (MSN-PVP-PEG-FA,
covalently labeled with Atto 633; 25 µg mL−1) for 2 h at 37 °C
under a 5% CO2 humidified atmosphere. After the incubation
the cells were washed three times with PBS (life technologies),
and 4% paraformaldehyde (PFA, Science Service) was added
for 15 min. The PFA was removed and the cells were washed
again three times with PBS. For staining the cell membrane,
the cells were incubated with a final concentration of 10 μg
mL−1 wheat germ agglutinin Alexa Fluor 488 conjugate (WGA
488, life technologies) for one minute. The cells were washed
once with PBS and imaged.
Cargo release experiments. To measure the photoactivated
cargo release the cells were incubated with particles
(MSN-PVP-PEG-AlPcS2a-FA, 25 μg mL−1) for 16–20 h at 37 °C
under a 5% CO2 humidified atmosphere. For imaging the
medium was replaced by CO2-independent medium (life
technologies), during the measurements the cells were kept on
a heated microscope stage at 37 °C. For activation of the photo-
sensitizer, the cells were irradiated with 1.2 W mm−2 of
639 nm light for 1 min. The release of cell-membrane per-
meable cargo due to pH-dependent opening of the PVP-
coating inside the endosomes was also measured. In the case
of colchicine-release, tubulin GFP expressing HuH7 cells were
incubated with particles (MSN-PVP-PEG-NH2 loaded with Col-
chicine, 100 μg mL−1) for 18 h at 37 °C under a 5% CO2
humidified atmosphere. In the case of DAPI-release, HeLa
cells were incubated with particles (MSN-PVP-PEG loaded with
DAPI, 25 µg mL−1) for 15 min, 15 h and 46 h under a 5% CO2
humidified atmosphere.
MTT assay. Bladder carcinoma T24 cells were seeded into
96-well plates at a density of 2500 cells per well in 100 µL
DMEM 4.5 g L−1 glucose growth media 24 h prior to
treatment. Medium was replaced by fresh growth medium
with MSN-PVP-PEG-NH2, unfunctionalized MSN,
MSN-PVP-PEG-NH2 loaded with doxorubicin (108 µg mL
−1;
50 µg doxorubicin per 1 mg particles) or doxorubicin (10 µM).
Particle concentration was calculated to achieve the desired
doxorubicin concentration (10 µM) per well. After 24 h or 48 h
incubation time, 10 µL of MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) solution (5 mg mL−1, Sigma-
Aldrich) were added to each well and plates were incubated for
2 h at 37 °C. Afterwards the medium was removed and cells
were lysed by freezing at −80 °C for 30 min. 100 µL DMSO
were added and plates were incubated at 37 °C for 30 min
under shaking. Absorption at 590 nm was measured against a
reference wavelength of 630 nm using a SpectraFluor Plus
microplate reader (Tecan, Groedig, Austria). Cell viability was
calculated as percentage of wells treated with HEPES (20 mM,
Biomol GmbH) with 5% glucose (Merck) (HBG).
3. Results and discussion
3.1. Synthesis and particle characterization
Colloidal core–shell mesoporous silica nanoparticles (MSNs)
with amino-moieties on the shell were synthesized via a
delayed co-condensation approach according to a published
synthesis procedure with CTAC as structure directing agent
and TEOS as silica source.19 The outer surface of the template-
free MSNs was subsequently modified with bi-functional poly-
(2-vinylpyridine) (PVP) via an EDC-assisted amidation reaction
(cf. Experimental section, Fig. 1 and ESI Fig. S1‡). The bi-func-
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tionality of the polymer allows the subsequent attachment of
PEG, fluorescent dyes and targeting ligands.
According to transmission electron microscopy (TEM), the
shell functionalized mesoporous silica nanoparticles show an
average particle diameter of 90 nm with a wormlike pore struc-
ture (Fig. S13a‡). The stepwise functionalization with poly-
(2-vinylpyridine) and PEG was monitored with several methods
(dynamic light scattering (DLS), zeta potential, and nitrogen
adsorption, Fig. 2A–C, Fig. S4‡) and is discussed in the follow-
ing (further spectroscopic details, IR and Raman spectra, in
ESI Fig. S2 and S3‡).
DLS measurements revealed the need for PEG as stabilizing
agent. The hydrodynamic diameter of amino shell-functiona-
lized MSN in aqueous media reveals an average particle size of
160 nm (Fig. 2A, black curve), whereas the polymer-modified
sample MSN-PVP-NH2 (red curve) shows strong aggregation in
aqueous media due to their hydrophobicity at pH 7, indicated
by an apparent size increase to 550 nm. However, subsequent
PEGylation of PVP recovers the colloidal nature of the system,
which is indicated by a decrease of the average apparent par-
ticle size (blue curve). Additionally, zeta potential titration
experiments of the samples MSN-NH2, MSN-PVP-NH2,
MSN-PVP-COOH and MSN-PVP-PEG-NH2 were carried out to
prove the functionalization of the synthesized inorganic–
organic hybrid material (Fig. 2B and Fig. S4‡). The high zeta
potential (+50 mV) of MSN-PVP at low pH reflects the polymer
cap system in its fully protonated and thus open state. At pH =
5.5, close to the pKa value of protonated pyridine, deprotona-
tion of the polymer cap system occurs, leading to a significant
drop in zeta potential with increasing pH. Together with the
zeta potential, DLS measurements were performed simul-
taneously at the same pH values. For MSN-PVP the particles
showed good colloidal dispersability as long as the polymer
remained in its protonated state (Fig. 2B). Upon deprotona-
tion, the polymer collapses at the particle surface, forming a
hydrophobic shell around the particles, which is revealed in
the increase in size due to agglomeration. In contrast, attach-
ment of PEG blocks to the PVP-functionalized particles led to
the suppression of aggregation, as no changes in size were
observed over the whole pH-range for MSN-PVP-PEG. In order
to show the ability of poly(2-vinylpyridine) to act as a pH
responsive cap system, nitrogen sorption measurements were
performed (Fig. 2D). To observe the open form (MSN-PVPopen),
the particles where dried from a 0.01 M HCl dispersion at
60 °C; this was expected to keep the protonated PVP functiona-
lized MSN in an open state. The closed state could be
measured after drying from a dispersion in Millipore water
(pH 7). In the open state, the mesopores are highly accessible,
whereas the polymer completely blocks the pores in the closed
state, even for very small molecules like nitrogen. The BET
surface area of 51 m2 g−1 in the closed state is in very good
agreement with an estimated external BET surface area of
45 m2 g−1 of spheres with similar density and diameter. The
BET surface area of 51 m2 g−1 for MSN-PVPclosed corresponds
to a reduction in surface area of 95% compared with MSNs
without polymer cap system (MSN-NH2), indicating that the
surface of the pore walls after blocking is not even accessible
for nitrogen. The key features of the different MSNs are sum-
marized in Table 1.
The decrease of the specific surface area in the sample
MSN-PVPopen can be explained by the addition of non-porous
Fig. 1 Concept of the pH-responsive delivery system. The pores can be
reversibly opened and closed through changes in the water solubility of
the polymer.
Fig. 2 Characterization of the functionalized MSN: (A) dynamic light scattering data of MSN-NH2 (black), MSN-PVP-NH2 (red) and
MSN-PVP-PEG-NH2 (blue), (B) titration experiments showing the zeta potential of MSN-PVP (black), and dynamic light scattering of MSN-PVP (red)
and MSN-PVP-PEG (blue), respectively, (C) nitrogen physisorption measurements of MSN-NH2 (black), MSN-PVP in the open state of the polymer
(red) and MSN-PVP-closed (blue).
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PVP and the blocking of some pores by frozen polymer on the
surface layer of the MSNs. This effect is comparably large due
to the length of the PVP.
3.2. Targeting
To design an effective drug delivery system, a targeting system
is highly desirable. Generally one can distinguish between
passive and active targeting. Modifications such as attaching
PEG at the surface of the delivery system provide shielding
against undesired interactions, and therefore favor the
enhanced permeability and retention effect (passive targeting).
Active targeting, on the other hand, takes advantage of the
overexpression of certain receptors on diseased cells by attach-
ment of the corresponding targeting ligand to the delivery
vehicle.49 Accordingly, active targeting was shown in vitro
using the example of folic acid (FA) receptor targeting on KB-
cells.
The attachment of active targeting ligands is important for
creating a functional drug delivery system.49 Folic acid was
chosen as targeting ligand because it is an ideal model system
for targeting with a small molecule and is also believed to be a
promising candidate for clinical applications.50 Furthermore,
the covalent binding of folic acid to the particles can be
achieved with an EDC-mediated coupling and could be easily
substituted by other targeting ligands without changing the
coupling chemistry. To demonstrate the functionality of the
particles, they were incubated with KB-cells, which are known
to overexpress FA-receptors.50 In a competition experiment,
with either free folic acid to block the FA-receptors or with
uninhibited FA-receptors, the uptake of MSN-PVP-PEG-NH2-FA
particles and hence the targeting abilities were monitored. For
the visualization of nanoparticle-uptake, z-stacks of the cells
were recorded with a spinning disk confocal fluorescence
microscope, which allowed us to determine MSNs inside or
outside the cells after staining the cell membrane.
In Fig. 3, typical confocal cuts through the cells together
with the orthogonal projection are shown. In the case of pre-
incubation with free folic acid, only a few individual particles
are present inside the cells (Fig. 3A), and also in the full stacks
the quasi-absence of nanoparticles is noted, independent of
the chosen focal plane. In contrast, incubation of
MSN-PVP-PEG-NH2-FA on KB-cells without pre-incubation of
FA resulted in significant uptake of particles (Fig. 3B). The par-
ticles appear in the representative z-slice as well as in the
entire height of the cell as shown in the orthogonal views.
In the case of blocked receptors, only unspecific uptake is
expected to occur, therefore the results demonstrate the
specific folate-receptor mediated endocytosis within two hours
with only a minor rate of unspecific uptake.
3.3. Release experiments
To verify the release properties of the particle-system, several
experiments were performed. First, the pH dependency was
tested in vial, in a cuvette system, at pH 7 and pH 5 (Fig. 4). In
a second approach, the multifunctional MSNs were tested
in vitro. For these experiments, membrane-permeable (DAPI,
colchicine, doxorubicin) and impermeable (calcein) dyes/drugs
were adsorbed in the mesopores of the MSNs and the cargo-
loaded nanoparticles were incubated with cells to prove the
functionality of the system on a cellular level. Membrane-
impermeable cargos cannot escape from the endosomal com-








MSN-NH2 1097 3.78 0.79
MSN-PVPopen 617 3.42 0.36
MSN-PVPclosed 51 — —
Fig. 3 Unspecific and receptor-mediated uptake of MSN-PVP-PEG-NH2-FA particles by KB cells. (A) Incubation of MSN-PVP-PEG-NH2-FA particles
with FA pre-incubated KB cells for 2 h at 37 °C. (B) Incubation of MSN-PVP-PEG-NH2-FA particles with KB cells, no free FA in cell culture medium,
for 2 h at 37 °C. The KB cell membrane is shown in green (dye WGA 488) and the particles in red (dye Atto 633). Orthogonal views are given to illus-
trate the uptake more clearly. The scale bars represent 10 µm.
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partments, therefore a photosensitizer (AlPcS2a) was covalently
attached to the outer surface of the sample MSN-PVP-PEG.16
The pH-responsive opening of the polymer cap system was
demonstrated by time-based fluorescence release experiments
with our custom-made release setup.51,52 For this purpose, a
distinct amount of fluorescein-loaded MSN-PVP-NH2 (Fig. 4,
blue curve, or MSN-PVP-PEG-NH2 (red), respectively) was exam-
ined in the closed state of the polymer for 2 h before the
sample was acidified, allowing a subsequent opening of the
pores and the diffusion of cargo molecules.
All intensity values are normalized to the highest obtained
fluorescent counts of the respective sample. Therefore, the
highest amount released is set to 100% relative release. The pH-
dependent release curves show the striking capping effect of the
poly(2-vinylpyridine) cap system. At pH 7, the polymer is in its
hydrophobic state and thus successfully blocks the pores of the
MSN until the release is triggered by decreasing the pH. In
acidic media, the polymer changes into its water soluble hydro-
philic state through protonation, which allows the cargo to
diffuse out of the pores. No significant changes in release kine-
tics are observed by further attachment of PEG compared with
sample MSN-PVP (Fig. 4) The total amount of cargo released
from the MSN could be calculated to 21 µg dye per mg MSN.
Long-term release experiments showed that even after 16 h, the
premature release is less than 4% (see ESI Fig. S6‡).
The controlled release of cargo inside the desired tissue is
one of the greatest challenges in drug delivery. Many systems
have been developed and characterized, including fusion,
redox-sensitive systems and photoactivation.40 Some of these
systems exhibit already a good temporal and spatial control of
the cargo-release. But once they are activated, the release
of the cargo is continuous, even if the particles leave the tissue
of interest. One advantage of our newly developed system is
the reversibility of the pore opening. If the pH of the environ-
ment turns neutral again, the PVP capping system should be
able to close the pores again and the delivery system can safely
circulate inside the blood system.
To safely deliver membrane-permeable cargos like DAPI,53
doxorubicin or colchicine54 inside cells with our newly develo-
ped system, the implementation of additional endosomal
escape mechanisms is not necessary. It is anticipated that the
particles will be taken up in endosomal compartments, and in
the following the endosomes get acidified. This drop in pH
from around 7 to approximately 5 results in the solvation of
poly(2-vinyl pyridine) and thus in release of the cargo from the
pores into the endosome, and consequently into the cytosol if
it diffuses through the endosomal membrane. On the other
hand, if the particles get exocytosed the pH will increase and
poly(2-vinyl pyridine) will turn insoluble again. In this case the
cargo will stay inside the particles and the latter can circulate
again and possibly find a new target cell. DAPI and colchicine
were used as model systems to examine the delivery of membrane
permeable cargo. DAPI preferentially stains dsDNA and thereby
produces a fluorescence enhancement of around 20-fold.55
Fig. 5 shows the staining of the nucleus after several time
intervals. Shortly after incubation only a weak staining of the
nucleus can be seen, after 15 h the nucleus is clearly visible
and after 46 h even the region of the endoplasmic reticulum
gets stained. Because of the slowly increasing and very strong
DAPI-fluorescence signal after several hours of incubation,
Fig. 4 Time based fluorescence release experiment of MSN-PVP-NH2
(blue) and MSN-PVP-PEG-NH2 (red) with fluorescein as cargo. Only
after change (from pH 7) to acidic pH (PH 5) a significant cargo release
can be detected.
Fig. 5 Fluorescence microscopy of HeLa cells incubated with DAPI-loaded MSN-PVP-PEG. MSN-PVP-PEG loaded with DAPI (blue) and labeled
with Atto 633 (red) after (A) 15 min (B) 15 h and (C) 46 h incubation with the cells. The nucleus region is indicated with dashed white lines. The scale
bar represents 10 µm.
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it could be excluded that the staining is due to free DAPI in
the particle solution. In the case of free DAPI in the solution,
the staining would be expected to be detectable shortly after
addition, as the typical incubation time for nucleus staining
with free DAPI in solution is only between 1–5 minutes.
The second cargo colchicine hinders the polymerization of
microtubuli as it binds to free tubulin.54 It is blocking the for-
mation of the mitotic spindle but not the mitosis itself. For
this study stable GFP-transfected liver carcinoma cells (HuH7)
were used, such that GFP is attached to the tubulin network. In
Fig. S12a‡ a picture of untreated HuH7 cells with GFP tagged
on the tubulin network is depicted; one can clearly see the
fibrous tubulin network. As shown in Fig. S12b,‡ MSN-PVP-PEG
particles loaded with colchicine were incubated for 18 h, and as
clearly seen, the fibrous structure has vanished completely,
because the formation of the tubulin network is hindered.
The delivery behavior of cell-membrane impermeable
cargos was investigated in a second step. Due to the acidic pH
inside late endosomes or lysosomes,56 cargo encapsulated
inside the PVP-capped MSN should be able to diffuse out of
the mesopores after reaching these compartments. The
inability of calcein to cross endosomal membranes was
demonstrated with calcein-loaded MSN-PVP-PEG particles by
incubating them for several hours on HeLa cells (cf. ESI
Fig. S9‡). As supposed, the calcein fluorescence stayed co-loca-
lized with the dye-labeled particles, which demonstrates that
the decrease in pH is not able to induce endosomal escape.
Therefore the system had to be further enhanced for the induc-
tion of endosomal escape.
Thus the photosensitizer AlPcS2a (PS) was covalently linked
to the PEG-chains, in addition to the pH-sensitive polymer on
the particle surface. Endosomal escape was expected to occur
after acidification of the endosomes and activation of the
photosensitizer with red laser light. After activation with red
laser light (639 nm, 1.2 W mm−2) singlet oxygen is produced,
which can destroy the endosomal membrane. We emphasize
that the lifetime of the singlet oxygen is very short (around 2 ×
10−7 s57), thus its diffusion range is limited and therefore the
cargo and also the cell membrane should stay intact, due to
the spatial separation of cargo, cell membrane and PS. More-
over, the red light used for activation of the photosensitizer is
in a useful region for medical applications and is already used
in photodynamic therapy.58 Previous studies from our groups
have already established “surgical” endosomal release using
covalently attached photosensitizers. It was demonstrated that
the activation of singlet oxygen only influences endosomes
containing MSN with covalently bound photosensitizer, while
the movement along microtubules for non-particle containing
endosomes was unaffected.59
For the photoactivated release experiment,
MSN-PVP-PEG-AlPcS2a/FA particles were incubated on HeLa
cells for 18 h. As seen in Fig. 6, calcein and PS are co-localized
(yellow spots, Fig. 6C). Directly after 1 min photoactivation
with 1.2 W mm−2 of 639 nm light, calcein-spreading over the
whole cell can be observed, and the calcein-fluorescence gets
brighter over time due to de-quenching of the dye upon escape
from the MSN host (Fig. 6E, I, M). In comparison to the emis-
sion from calcein, the fluorescence of the photosensitizer stays
localized in the same dot-like pattern as prior to the photoacti-
vation, only the intensity is reduced because of photo-bleach-
ing effects after the activation (Fig. 6F, J and N). The intensity
profile along the white line, indicated in the merged pictures,
depicts the fluorescence increase due to calcein more clearly
(Fig. 6D, H, L and P). The cargo release can also be visualized
with a constant PS-activation and simultaneous observation of
calcein fluorescence (over a period of 8 min; Fig. S10‡). Strik-
ingly, a significant part of the cargo appears to be released
inside the cell already within two minutes.
The above results were compared to those of incubation
experiments of cells with a solution of free calcein and PS. As
seen in Fig. S11,‡ the amount of internalized calcein is negli-
gible. We also observe that the free PS is spreading over the
entire cell. If the PS is not covalently bound to an MSN, the
molecules can diffuse inside the whole cell and can cause
much more damage to the cell membrane and other orga-
nelles due to their greater proximity.
The release of a pharmacologically relevant cargo was also
investigated. For this purpose we performed MTT assays of
bladder carcinoma T24 cells with MSN-PVP-PEG-NH2,
uncoated MSN, MSN-PVP-PEG-NH2 loaded with doxorubicin
and free doxorubicin for 24 and 48 hours. The concentration
of particles was calculated on the basis of loaded doxorubicin,
such that at the end similar amounts of doxorubicin were deli-
vered. As compared with free doxorubicin, the cell killing kine-
tics by the doxorubicin loaded MSN particle was delayed
(Fig. 7). After 24 hours the cell viability was 54.5 ± 2.8% for
free doxorubicin, but 70.9 ± 4.7% for the doxorubicin loaded
particles (MSN-NH2: 99.3 ± 7.9%; MSN-PVP-PEG-NH2: 77.6 ±
5.6%). However, after 48 hours the cell viability for doxorubi-
cin-loaded particles had decreased to 39.1 ± 1.6% (Dox: 31.0 ±
2.4%; MSN-NH2: 97.0 ± 10.8%; MSN-PVP-PEG-NH2: 79.7 ±
7.6%). Apparently our MSN-based system needs time to open
up the pores in the acidic endolysosomal compartments and
slowly releases the drug over time. Variations in the dox-
loading and release kinetics of MSN-PVP-PEG-NH2 can lead to
a slight differences in the cell viability compared to free dox
after 48 h. Nevertheless a comparable reduction in cell viability
can be observed for free Dox and the Dox loaded particles.
3.4. Stability tests of the nanoparticles
Previous studies on the effect of functionalization of MSN on
their bio-degradation demonstrated the fast degradation of
pure, unprotected MSN in simulated body fluids.11,60 The
attachment of poly(ethylene glycol) significantly increased the
stability up to several days, whereas the un- or organo-silane
functionalized MSN lost their porosity in the first hours of
incubation. During the partial hydrolysis and dissolution of
the silica material, hydroxyapatite layers precipitated on the
surface of the silica by adsorption of Ca2+ ions in the porous
system and via hydrogen bonding of PO4
3− ions.11,60 The
functionalization with PEG already enhanced the stability of
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the MSNs, but the PEG-layer does not close the pores of the
MSNs. In contrast, in the case of PVP-functionalization the
particles are completely protected from the environment as
long as they stay in neutral or basic milieu. The stability of the
MSN was tested (i) in bio-fluids and (ii) for storage purposes in
order to estimate shelf life. Biostability assays were performed
to test whether the polymer cap system will prevent the meso-
porous silica nanoparticles from degradation. This was done
using Dulbecco’s Modified Eagle’s Medium (DMEM) at 37 °C
at two different pH values (5 and 7). As a widely used basal
medium for growing many mammalian cells, DMEM contains
various amino acids, vitamins and inorganic salts, amongst
others and is used here to simulate a biological environment.
Samples were removed after specific times, washed and dried.
The nanoparticles were then characterized with transmission
electron microscopy and nitrogen sorption. TEM images show
significant degradation of the nanoparticle structure for
unfunctionalized MSN after 24 h immersion at pH 7 (see ESI
Fig. S12b‡), which is in good agreement with results of similar
experiments reported earlier.11 In contrast, nanoparticles func-
tionalized with PVP offer very good stability in DMEM at pH
7. At this pH, the polymer cap system forms a tight, hydro-
phobic, and therefore impermeable envelope for water, pro-
teins and salts around the MSN. Additionally, the polymer
shell improves the stability of the MSN in DMEM at pH 5,
where the cap system is in its open state. In comparison with
Fig. 6 Fluorescence microscopy of MSN-PVP-PEG-AlPcS2a-FA nanoparticles loaded with calcein after 18 h incubation on a HeLa cell. (A–C)
Calcein (green) and AlPcS2a (red) are co-localized (yellow) prior to photoactivation. (D) Intensity profile along the white line in the merged image.
The red line indicates photoactivation with 1.2 W mm−2 of red light (639 nm). (E–H) After 1 min photoactivation, (I–L) 5 min after photoactivation,
(M–P) 10 min after photoactivation. The scale bar represents 10 µm.
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uncoated nanoparticles, MSN-PVP particles show less degra-
dation, which was also confirmed by nitrogen sorption experi-
ments (Fig. S14 and S15‡). In both cases, in the open and the
closed state of the cap system, no changes in the pore size dis-
tribution were observed, indicating that the pores are not
affected by the medium.
In order to test the stability of the MSN under storage con-
ditions, the functionality of 4-week-old particles (stored at
4 °C) could be verified with in vitro release experiments
(Fig. S16‡). After storage in water (and therefore in a closed
state of the PVP) the particles retain the same calcein release
behavior in cells as already demonstrated in Fig. 5.
Drying and re-dispersion of MSN-PVP-PEG-NH2 in water
exhibits no significant agglomeration of the particles or any other
visible change of their solution behaviour (DLS measurement in
Fig. S17‡). This remarkable behavior is exceptional for meso-
porous silica nanoparticles; the common response to drying is
serious agglomeration that cannot even be broken with ultra-
sound. Based on the redispersibility of the nanoparticles after
drying, a long shelf life of the nanoparticles is expected.
4. Outlook
In this work, we have developed a multifunctional drug deli-
very vehicle based on polymer-functionalized mesoporous
silica nanoparticles. This system combines attractive features
such as the high loading capacity of MSNs with the tuneable
functionality of a polymer. The use of bis-functionalized
polymer blocks allowed us to covalently attach step-by-step
many functionalities of interest. We demonstrate that co-
valently bound poly(2-vinylpyridine) in combination with a
PEG-block acts as a pH-responsive cap system for MSN. With
this system, we show the successful delivery of different cargos
into cells. Membrane permeable cargos were delivered without
any external trigger, because such cargos could penetrate the
endosomal membrane. Covalent attachment of a red-light-
photosensitizer offered the possibility to open the endosome
through irradiation with laser light, and to deliver membrane-
impermeable cargos. Effective targeting of folic acid receptor
expressing cells was enabled by the covalent attachment of
folic acid. Stability tests revealed the effectiveness of poly(2-
vinylpyridine) not only as cap system, but also as a highly
effective protecting agent for MSN against aggressive body
fluids. Strikingly, the polymer-coated nanoparticles can even
be dried and then re-dispersed in water without causing
agglomeration, which bodes well for a long shelf life of the
dried particles. Preliminary biodistribution experiments of
MSN-PVP-PEG nanoparticles in vivo revealed no particle
agglomeration and showed preferred liver accumulation. The
modified and unmodified MSN were well tolerated in mice
without causing visible side effects, which was also confirmed
by blood parameter and histopathological examination (cf.
ESI‡). With this new system we have developed a multifunc-
tional toolbox based on MSNs that is able to open and close its
cap system depending on the environment. One major advan-
tage of our system derives from the covalent attachment of all
components, which allows the system to operate for several
cycles. We anticipate that the possible integration of almost
any functionality of interest as well as the efficient synthesis
make this system promising for wide-ranging biological and
medical applications, especially in cancer therapy.
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